Oxycodone HCL-Acetaminophen Tablets

SPE2D2-22-D-0150 P00009 to invoke Option Year 4

SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).

SPE2D2-22-D-0150 P00007 to invoke Option Year 3

SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders.

SPE2D2-22-D-0150 P00005 to invoke Option Year 2

SPE2D2-22-D-0150 P00003 to invoke Option Year 1 

SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract. 

SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract. 

Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.

SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract. 

SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract. 

Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.

Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.